27/06/2019
Q3 Medical Devices Limited enters into a Distribution Agreement with Medtronic for its Biodegradable Biliary and Pancreatic Stent. The product will also be available in Romania, through Sovereign Medical
Q3 Medical Devices Limited (“Q3 Medical”) based in Dublin, Ireland, announced today that it has entered into a distribution agreement with Medtronic plc for ARCHIMEDES, the first to market fully biodegradable biliary and pancreatic stent designed as an alternative to traditional plastic stents.